
Pharmacists can improve cardiometabolic adherence by easing adverse effects, simplifying regimens, tackling costs, and synchronizing refills.
Baxter issues voluntary recall of heparin
Reported adverse events associated with Baxter's heparin sodium injection 1000 units/ml have prompted the company to recall certain lots of the product while it investigates the cause. The affected lots include both 10-ml and 30-ml vials. The 10-ml vials affected are from lots 107054 and 117085. The 30-ml vials affected include lots 047056, 097081, 107024, 107064, 107066, 107074, and 107111. A complete list of reported adverse events can be found at






